Login to Your Account



Cansino lands $65M to fund global vaccine development, new plant

By Shannon Ellis
Staff Writer

Wednesday, April 19, 2017

SHANGHAI – Chinese vaccine developer Cansino Inc., of Tianjin, has received $65 million in a financing round led by Future Industry Investment Fund to hasten the development of its later-stage vaccines and get a new vaccine plant up and running.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription